202 Matching Annotations
  1. Jun 2021
  2. Jan 2021
    1. AJV

      CaseAJV: 17 years diagnosis, Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: Father (index case) died awaiting cardiac transplant (carried both variants). Two possibly affected relatives.

      CasePresentingHPOs: HP:0001639, HP:0006536

      (Hypertrophic cardiomyopathy, Obstructive lung disease)

      HPOsFreeText: Maximum left ventricular hypertrophy at 17 mm, Sudden cardiac death event at 17 years, Maximal wall thickness at 22mm,

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant:NM_000257.3:c.1954A>G (p.Arg652Gly)

      ClinVarID:177626 https://www.ncbi.nlm.nih.gov/clinvar/variation/177626/

      gnomAD: Not in gnomAD

      Multiple Gene Variants:

      MYBPC3 Variant

      Variant: NM_000256.3:c.2980C>T (p.Leu994Phe)

      ClinVarID:180992 https://www.ncbi.nlm.nih.gov/clinvar/variation/180992/

      gnomAD: European (Non-Finnish) 1.624e-4, Overall 8.461e-5 https://gnomad.broadinstitute.org/variant/11-47355487-G-A

  3. Dec 2019
  4. Oct 2019
  5. Sep 2019
    1. APPENDIX C:SEMIDOMINANT MODE OF INHERITANCE OVERVIEW

      New section that outlines examples on how to score Semidominant mode of inheritance in the GCI.

    2. PMID: 18853439

      Using these PMIDs allows a curator to score applicable evidence within the GCI that is included as part of a general, large resource database.

    3. APPENDIX A:

      This section was updated to include new useful websites, including PMIDs to use for curation purposes on websites that may house important evidence (e.g. The Human Protein Atlas, MGI, IMPC, etc). A new section entitled Case-Level databases was added to provide curators with information on well-known sites containing case-level genetic evidence that may be applicable to scoring for a given gene-disease relationship.

    4. RECURATION PROCEDURE

      New section that outlines the procedures for all GCEPs to follow for recuration of gene-disease relationships under their purview. A hyperlink to the full recuration document is included.

    5. General Considerations for Variant Evidence Scoring:

      Updated section that provides guidance and recommendations for upgrading and downgrading default variant scores based on several lines of evidence, including mode of inheritance, computational predictors, population frequency, disease mechanism, phenotype, and constraint metrics.

    6. Recurrent variants:

      New section that provides examples, guidance and recommendations for the evaluation of recurrent variants, or variants that have been observed multiple times for a given gene-disease relationship.

    7. Figure 3. Genetic evidence matrix footnotes

      New section that outlines important information on the matrix including max points per variant type and category, and information on how to manually override a calculated gene-disease validity classification in the GCI (visual representation on Figure 4, p18).

    8. Mode of inheritance (MOI):

      New section that outlines the current “Mode of inheritance” (MOI) options available in the GCI and how they affect the ability to score and/or publish gene-disease validity classifications to the website. A new table visually outlines the MOIs and scoring, approving, and publishing capabilities (Table 1).

    9. ESTABLISHING THE GENE-DISEASE-MODE OF INHERITANCE

      This is a new section outlining the process of selecting a gene, disease, and mode of inheritance. Hyperlinks to supportive resources, such as the ClinGen Lumping and Splitting guidelines, GeneTracker, etc. are provided.

    10. NO KNOWN DISEASE RELATIONSHIP3

      The classification of “No reported Evidence” has been updated to “No known disease relationship” in order to align with the new terminology recommendation from the international Gene Curation Consortium (GenCC).

    1. Hypothes.is Gene Annotation SOP v1

      The Hypothes.is Gene Annotations SOP version 1 is located under the "Additional Supporting Materials Tab."

      This protocol outlines procedures for annotating and tagging applicable gene curation evidence and is structured to capture fields required for the ClinGen Gene curation Interface (GCI).

  6. Aug 2019
    1. Hypothes.is Gene Annotation SOP v1

      The Hypothes.is Gene Annotations SOP version 1 is located under the "Additional Supporting Materials Tab."

      This protocol outlines procedures for annotating and tagging applicable gene curation evidence and is structured to capture fields required for the ClinGen Gene curation Interface (GCI).

    1. Table of Contents

      The Table of Contents is now interactive and “clickable.” Clicking on a section title will take the reader to the section of interest.

    1. Gene-Disease Validity Standard Operating Procedures, Version 7

      Click the following link to see SOP version 7 updates using Hypothes.is annotation. These notes will be similar to the HIGHLIGHTED version of the SOPv7.

  7. May 2019
  8. Mar 2019
  9. Feb 2019
  10. Dec 2018
  11. Nov 2018
  12. Aug 2018
  13. Jul 2018
  14. Jun 2018